Summary
Penbutolol is a potent long-acting non-cardioselective beta-adrenergic blocker with partial agonist activity. A double-blind cross-over comparison of penbutolol given in a single daily dose and propranolol given twice daily in the treatment of ambulant patients with moderate hypertension is described. Fourteen patients completed the study and were treated with each drug for 12 weeks. Penbutolol in daily doses of 20–120 mg and propranolol in daily doses of 80–400 mg produced similar significant reductions in both supine and erect blood pressure. Penbutolol did not reduce heart rate to the same extent as propranolol, in equivalent doses. Penbutolol appears to produce adequate control of moderate hypertension when administered once a day, and this effect appears to be equivalent to divided doses of propranolol. No serious adverse effects were reported, although one patient receiving penbutolol experienced severe eye pains at a dose of 40 mg which resolved on crossing over to treatment with propranolol.
Similar content being viewed by others
References
Haertfelder G, Lessenich H, Schmitt K (1972) Penbutolol (Hoe 893 d), ein neues, stark wirksames Beta-Sympatholytikum mit langer Wirkungsdauer. Arzneimittel-Forsch. 22: 930–932
Nyberg G, Wilhelmsson C, Vedin A (1979) Intrinsic Sympathomometic Activity of Penbutolol. Eur J Clin Pharmacol 16: 381–386
Boissier J-R, Coutte R, Advenier C, Giudicelli J-F (1973) Activité Beta-adrénolytique et effets hémodynamiques du penbutolol. Thérapie 28: 1251–1265
Haertfelder G, Kaiser J (1973) Pharmacology of Penbutolol (Hoe 893 d) a new strong and long-lasting effective beta-sympatholytic. Naunyn-Schmiedeberg's Arch Pharmacol 277: R 26
Boissier JR, Coutte R, Bertin MC, Guidicelli J-F (1974) Effets anti-arhythmisants du penbutolol. Thérapie 29: 261–269
Giudicelli J-F, Richer C, Chauvin M, Idrissi N, Berdeaux A (1977) Comparative β-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man. Br J Clin Pharmacol 4: 135–140
McLean Baird I, Hill H, Ings RMJ, Johnson KI, McEwen J (1977) Dynamic and Kinetic comparison of penbutolol and propranolol in healthy volunteers. Br J Clin Pharmacol 4: 386P
Frick MH, Hartikainen M, Pörski P (1978) Penbutolol, a new non-selective beta-adrenergic blocking compound in the treatment of hypertension. A comparison with propranolol. Ann Clin Res 10: 105–106
McEwen J, McLean Baird I (1976) Investigation of the duration of effect of propranolol and penbutolol using dynamic area under the curve of pulse rate versus time as a measure of inhibition of exercise induced tachycardia. Br J Clin Pharmacol 3: 965P
Boksay I, Arnold JD, Berger A, Mehta D (1979) The β-blocking activity of penbutolol (HOE 893 d), a new long-acting β-blocker, before, during and 4, 8 and 24 h after submaximal exercise. Clin Pharmacol Ther 25: 215
Hansson B-G, Hokfelt B (1975) Long term treatment of moderate hypertension with penbutolol (Hoe 893 d) I. Effects on blood pressure, pulse rate, catecholamines in blood and urine, plasma renin activity and urinary aldosterone under basal conditions and following exercise. Eur J Clin Pharmacol 9: 9–19
Westheim AS, Christensen CChr, Kjekshus J (1978) Effect of penbutolol (Hoe 893 d) and practolol on exercise-induced angina pectoris 2 and 24 h after a single oral dose. Eur J Clin Pharmacol 13: 157–162
Hillis WS, Tweddel AC, Murray RG, Lawrie TDV (1980) Comparative Study of the Effects of Penbutolol and Propranolol in the Treatment of Angina Pectoris. Arzneimittelforsch (In press)
Sainani GS, Shah GM, Nandi JS, Gulati RB (1977) A pilot study of once-daily penbutolol in hypertension. Pharmatherapeutica 1: 493–497
Yajnik VH, Nandi JS, Patel SC, Doshi HV, Patel SH (1977) Penbutolol in hypertension: a pilot study with single daily doses. J Int Med Res 5: 236–242
Raftery EB (1978) The methodology of blood pressure recording. Br J Clin Pharmacol 6: 193–201
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kubik, M.M., Hanks, G.W. Single daily dose penbutolol in the treatment of hypertension: A double blind crossover comparison with propranolol. Eur J Clin Pharmacol 17, 409–413 (1980). https://doi.org/10.1007/BF00570156
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00570156